Upgrade to SI Premium - Free Trial

Armata Pharma (ARMP)

7.56 -0.22 (2.83%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/18/26)

Latest Headlines

Form SCHEDULE 13D/A Armata Pharmaceuticals, Filed by: Innoviva, Inc. May 13, 2026 5:22 PM - SEC Filing Form 10-Q Armata Pharmaceuticals, For: Mar 31 May 13, 2026 4:50 PM - SEC Filing Form 8-K Armata Pharmaceuticals, For: May 12 May 13, 2026 4:34 PM - SEC Filing Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update May 13, 2026 4:30 PM - PR NewsWire Form 8-K Armata Pharmaceuticals, For: May 07 May 7, 2026 7:11 AM - SEC Filing Armata Pharmaceuticals receives FDA fast track status for AP-SA02 May 7, 2026 7:00 AM - StreetInsider Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02 May 7, 2026 7:00 AM - PR NewsWire Armata Pharmaceuticals Announces Structural Biology Publication in "Communications Biology" May 4, 2026 7:00 AM - PR NewsWire Form 4 Armata Pharmaceuticals, For: Apr 24 Filed by: Gilmer Daniel B. April 28, 2026 4:25 PM - SEC Filing Form 3 Armata Pharmaceuticals, For: Apr 24 Filed by: Gilmer Daniel B. April 28, 2026 4:23 PM - SEC Filing Form ARS Armata Pharmaceuticals, For: Dec 31 April 27, 2026 4:17 PM - SEC Filing Form DEF 14A Armata Pharmaceuticals, For: Jun 11 April 27, 2026 4:10 PM - SEC Filing Form 8-K Armata Pharmaceuticals, For: Apr 24 April 27, 2026 7:11 AM - SEC Filing Armata Pharmaceuticals adds Pfizer executive Daniel Gilmer to board April 27, 2026 7:00 AM - StreetInsider Armata Pharmaceuticals Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.D. to its Board of Directors April 27, 2026 7:00 AM - PR NewsWire Armata Pharmaceuticals (ARMP) PT Raised to $20 at Jones Trading April 8, 2026 8:45 AM - StreetInsider Form 8-K Armata Pharmaceuticals, For: Apr 02 April 2, 2026 4:17 PM - SEC Filing Armata Pharmaceuticals, Inc. (ARMP) Misses Q4 EPS by 323c March 26, 2026 7:27 AM - StreetInsider Form 10-K Armata Pharmaceuticals, For: Dec 31 March 25, 2026 4:19 PM - SEC Filing Form 8-K Armata Pharmaceuticals, For: Mar 25 March 25, 2026 4:11 PM - SEC Filing Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results March 25, 2026 4:05 PM - PR NewsWire Form 8-K Armata Pharmaceuticals, For: Mar 19 March 19, 2026 7:10 AM - SEC Filing Armata Pharmaceuticals delays Q4 2025 earnings, gets FDA designation March 19, 2026 7:02 AM - StreetInsider Armata Pharmaceuticals Delays Announcement of Fourth Quarter and Full-Year 2025 Results and Provides Corporate Update March 19, 2026 7:01 AM - PR NewsWire Form 4 Armata Pharmaceuticals, For: Mar 14 Filed by: Kyme Pierre March 17, 2026 7:48 PM - SEC Filing Form 4 Armata Pharmaceuticals, For: Mar 14 Filed by: Birx Deborah March 17, 2026 7:47 PM - SEC Filing Full Article List